Ftse Mib
37.677,27
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.572,07
-0,76%
NASDAQ
17.436,10
-0,18%
Bitcoin
82.905,77
5,65%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Takeda Pharmaceutical Company Ltd (TAK) Takeda Pharmaceutical Company Ltd (TAK) Notizie

Takeda Pharmaceutical Company Ltd

TAK
14,90
-0,14 (-0,93%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 21:00:03
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/2/202509:01PRNUSThe European Medicines Agency (EMA) Has Approved an..
12/2/202514:06EDGAR2Form 13F-HR - Quarterly report filed by institutional..
30/1/202508:04BWJulie Kim Will Succeed Christophe Weber as CEO of Takeda in..
30/1/202507:35BWTakeda Delivers Strong Third-Quarter FY2024 Results; Raises..
29/1/202514:00PRNCAHéma-Québec to Reimburse HyQvia® for the Treatment of..
21/1/202514:00PRNCATakeda Recognized as a Top Employer in Canada for Third..
20/1/202514:00PRNCATakeda's FRUZAQLA™ (fruquintinib) Receives Health Canada..
27/12/202407:00BWTakeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous)..
19/12/202414:02PRNCATakeda parraine l'initiative de bourses de recherche sur les..
13/12/202401:00GLOBEHUTCHMED to Receive Milestone Payment from Takeda following..
12/12/202423:30BWTakeda Spotlights High-Value, Late-Stage Pipeline..
03/12/202413:00BWTakeda Strengthens Oncology Pipeline with Elritercept..
22/11/202405:30GLOBEHUTCHMED Announces Launch by Takeda of FRUZAQLA®..
04/11/202414:01PRNCAUn nouveau sondage souligne l'importance de prioriser la..
01/11/202404:57BWTakeda gibt starke Ergebnisse für das erste Halbjahr des..
01/11/202404:46BWTakeda annonce de solides résultats pour le premier semestre..
31/10/202409:30GLOBEHUTCHMED to Receive First Commercial Milestone Payment..
31/10/202407:06BW武田薬品工業: 2024年度上期の好調な業績を公表 - 通期の見通しを上方修正
31/10/202407:05BWTakeda Announces Strong First Half FY2024 Results and Raises..
24/10/202414:00BWTakeda and Boston Medical Center Announce Innovative..
24/9/202409:00GLOBEHUTCHMED Announces Japan Approval for FRUZAQLA®..
19/9/202414:00BWTakeda to Present Additional Clinical Trial Study Data..
19/9/202406:38BWTakeda s'engage à verser plus de 32 millions de dollars dans..
19/9/202406:36BWTakeda stellt über 32 Mio. US-Dollar für fünf neue globale..
18/9/202416:00BW武田薬品工業: 5つの新しいグローバルCSRパートナーシップに3,200万ドル以上を拠出し、93カ国における健康増進を支援
16/9/202414:40PRNCAVatroslav Mateljic est nommé directeur général de Takeda..
16/9/202414:39PRNCAVatroslav Mateljic Appointed General Manager of Takeda..
07/8/202412:45BWTakeda Receives European Commission Approval for ADZYNMA®▼..
01/8/202400:17BWTakeda annonce ses résultats financiers pour le premier..
01/8/202400:07BWTakeda gibt Ergebnisse für das erste Quartal des..
31/7/202413:46EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
31/7/202412:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/7/202411:59IHMARKETNEWSAMD Shares Surge 9% on Earnings Beat; Match Group Rises 10%,..
31/7/202408:06BW武田薬品工業: 2024年度第1四半期業績を公表 -..
10/7/202413:19EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:18EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:17EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:17EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:16EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:16EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:15EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:15EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:14EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:13EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:13EDGAR2Form 144 - Report of proposed sale of securities
10/7/202413:12EDGAR2Form 144 - Report of proposed sale of securities
10/7/202412:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/7/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/6/202401:43BWTakeda kündigt neue Besetzung der Direktorenposten an
27/6/202401:25BWTakeda annonce de nouvelles nominations de directeurs
Apertura: 15,04 Min: 14,83 Max: 15,07
Chiusura: 15,04

La tua Cronologia

NYSE
TAK
Takeda Pharmaceutical
AMEX
KOLD
ProShares UltraShort Blo...
TSXV
GGA
Goldgroup Mining
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci